Literature DB >> 19011870

[Acute retinopathy of prematurity].

B Lorenz1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 19011870     DOI： 10.1007/s00347-008-1786-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  13 in total

1.  Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.

Authors:  António Travassos; Susana Teixeira; Pinto Ferreira; Isaura Regadas; Ana Sofia Travassos; Florindo Esteves Esperancinha; Isabel Prieto; Grapa Pires; Robert van Velze; A Valido; Maria do Céu Machado
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2007 May-Jun

2.  Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture.

Authors:  Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-15       Impact factor: 4.799

3.  Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study.

Authors:  Lingkun Kong; Helen A Mintz-Hittner; Rebecca L Penland; Francis L Kretzer; Patricia Chévez-Barrios
Journal:  Arch Ophthalmol       Date:  2008-08

4.  Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs.

Authors:  Clare Gilbert; Alistair Fielder; Luz Gordillo; Graham Quinn; Renato Semiglia; Patricia Visintin; Andrea Zin
Journal:  Pediatrics       Date:  2005-04-01       Impact factor: 7.124

Review 5.  Retinopathy of prematurity: the life of a lifetime disease.

Authors:  William Tasman; Arnall Patz; J Arch McNamara; Richard S Kaiser; Michael T Trese; Bradley T Smith
Journal:  Am J Ophthalmol       Date:  2006-01       Impact factor: 5.258

6.  Do cortisol concentrations predict short-term outcomes in extremely low birth weight infants?

Authors:  Susan W Aucott; Kristi L Watterberg; Michele L Shaffer; Pamela K Donohue
Journal:  Pediatrics       Date:  2008-10       Impact factor: 7.124

7.  Randomized trial of very low birth weight infants receiving higher rates of infusion of intravenous fat emulsions during the first week of life.

Authors:  Douglas Drenckpohl; Connie McConnell; Shirley Gaffney; Matt Niehaus; Kamlesh S Macwan
Journal:  Pediatrics       Date:  2008-10       Impact factor: 7.124

8.  Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study.

Authors:  S Kusaka; C Shima; K Wada; H Arahori; H Shimojyo; T Sato; T Fujikado
Journal:  Br J Ophthalmol       Date:  2008-07-11       Impact factor: 4.638

9.  Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.

Authors:  Helen A Mintz-Hittner; Ronald R Kuffel
Journal:  Retina       Date:  2008-06       Impact factor: 4.256

Review 10.  Insulin therapy in preterm newborns.

Authors:  Kathryn Beardsall; David Dunger
Journal:  Early Hum Dev       Date:  2008-10-10       Impact factor: 2.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.